are a target of intracellular bacterial pathogens, which use a variety of mechanisms to subvert host PI metabolism (Pizarro-Cerdá and Cossart 2004; Hilbi et al. 2011; Hilbi 2006) . Many intracellular pathogens secrete effector proteins that directly modify the PI levels in the host, alter the activity of host PI-metabolizing enzymes, or bind to PIs for their proper intracellular targeting and function (Weber et al. 2009; Hsu et al. 2012; Toulabi et al. 2013) .
Intracellular pathogens have evolved many ways of performing similar tasks: uptake by host cells, evading host defenses to allow for intracellular replication, and introduction into the cytosol followed by egress from the host. For example, different species use a variety of mechanisms to enable uptake by host cells (Hilbi 2006) . Shigella flexneri and Salmonella enterica both use type III secretion systems (T3SS) to secrete PI phosphatases into the host cytosol, altering the membrane content and inducing the phagocytosis of the bacteria. Yersinia spp. and Mycobacterium tuberculosis utilize receptor-mediated endocytosis to invade their respective hosts. Once inside, infectious bacteria also have differing replication environment preferences. Salmonella, Legionella, and Mycobacterium each develop unique intracellular niches to avoid detection and replicate, while Brucella species replicate in the cytoplasm (Knodler and Steele-Mortimer 2003; Isberg et al. 2009; Russell et al. 2002; Gorvel and Moreno 2002) . The pathogenic life cycle concludes with the induction of host apoptotic pathways and lysis of the host cell, leading to the death of the host, with each pathogen using its own mechanism to do so (Alli et al. 2000; Ogawa et al. 2005; Gao and Kwaik 2000) . There is still much to be learned about the mechanisms of bacterial pathogenesis in each species, particularly the functions of the bacterial effector proteins.
A prime example of the exploitation of both the host PI and ubiquitin systems is Legionella pneumophila, a gramnegative intracellular pathogen whose natural host is freshwater amoeba. Legionella is an opportunistic pathogen of humans, causing a severe form of pneumonia termed Legionnaires' disease (Cunha 2015; Xu and Luo 2013) . Legionella uses an intracellular multiplication/defective organelle trafficking (Dot/Icm) type IV secretion system to secrete approximately 300 effector proteins into the host cytosol to hijack many host cellular processes, leading to the formation of a replicative niche for the bacteria, termed the Legionella-containing vacuole (LCV) (Hubber and Roy 2010; De Felipe et al. 2008) .
Currently, only approximately 10 % of the Legionella effector proteins have a described function, leaving much to be learned about these proteins and the infection itself. Difficulty in studying Legionella effectors arises from the high level of functional redundancy observed in these proteins. Indeed, entire families of secreted effectors can be deleted without the emergence of a phenotype in a Legionella infection. Of the effectors with known functions, many act to disrupt host pathways. For example, SidM/DrrA has been shown to be a PI(4)P-binding guanine nucleotideexchange factor (GEF) responsible for the recruitment of the host GTPase Rab1 to the LCV, while LepB acts as a Rab1 GTPase activating protein (GAP), serving to regulate the activity of SidM/DrrA (Murata et al. 2006; Ingmundson et al. 2007; Brombacher et al. 2009 ). There are also recent reports of effectors proposed to regulate other Legionella effectors, termed "metaeffectors." SidJ was shown to reduce the toxicity of the SidE family of effectors in yeast (Jeong et al. 2015; Havey and Roy 2015) . In addition, the U-box containing E3 ubiquitin ligase LubX directly targets SidH for degradation (Kubori et al. 2010) . The complexity of the action and regulation of so many effectors is just beginning to be understood. While the majority of the effector proteins remain to be characterized, one of these effectors, SidC (and its paralog SdcA), has been recently found to have multiple functions that serve to connect both the ubiquitin and PI pathways.
SidC was shown to associate with the LCV though a C-terminal PI(4)P-binding region and was suggested to play a role in the enrichment of both ER-derived vesicles and polyubiquitinated species on the LCV (Hilbi et al. 2011; Weber et al. 2006; Ragaz et al. 2008; Horenkamp et al. 2014 ). We and others determined the structure of the N-terminal domain of SidC, which contained a novel fold with an unknown function (Horenkamp et al. 2014; Gazdag et al. 2014; Hsu et al. 2014) . With careful sequence and structural analysis, we found a cluster of residues on the surface of the protein that was conserved across all SidC homologs. We observed that this cluster contained three highly conserved residues (C46, H444, and D446) arranged in a manner reminiscent of the classical Cys-His-Asp catalytic triad commonly found in cysteine proteases and deubiquitinases. However, after extensive trials we failed to detect any activity related to these hydrolytic enzymes. Surprisingly, a significant change in the ubiquitination pattern of the total cell lysate was detected in an experiment in which SidC was co-expressed with HA tagged ubiquitin in HEK293T cells. This observation led us to hypothesize that SidC may function as an E3 ubiquitin ligase, which was verified by in vitro ubiquitination assays. In addition, we found that SidC preferentially catalyzed K11 and K33-linked polyubiquitin chains. Thus, we named this novel N-terminal domain the SNL domain (SidC N-terminal ubiquitin Ligase).
Further structural studies led us to reveal the nearly full-length structure of SidC (Luo et al. 2015) . We found that the C-terminal PI(4)P-binding P4C domain assumed a four antiparallel α-helical bundle structure. A positively charged pocket formed at one end of this bundle was confirmed as the specific PI(4)P binding site. Intriguingly, the P4C domain masked the ubiquitin ligase active site though a hydrophobic interaction with a patch of residues near the catalytic cysteine. This "closed" conformation not only rendered SidC a lower ubiquitin ligase activity compared to the isolated SNL domain, but also a lower affinity for PI(4)P binding compared to the P4C domain alone. We found that SidC presented an increased ligase activity upon PI(4)P binding, presumably due to the "opening" of the catalytic site induced by PI(4)P. This regulatory mechanism seemed to be conserved in all SidC orthologs except that of Legionella longbeachae. In that species, the leucine residue that mediated the interaction between the SNL and P4C domains was altered to a glutamic acid. This substitution likely disrupted the hydrophobic interaction and gave L. longbeachae SidC a preference for the "open" conformation. In agreement with this observation, L. longbeachae SidC was shown to have ~3 fold increase in affinity for PI(4)P binding when compared to L. pneumophila SidC (Dolinsky et al. 2014) .
Our results indicate the discovery of another Legionella effector protein that merges two independent cellular pathways, by uniting a unique ubiquitin E3 ligase activity and the recognition of a specific PI in a single peptide. It remains to be seen if more bacterial effectors function to link multiple pathways together in a similar manner. These findings allow us to propose a model of SidC action. After Legionella infection, SidC is secreted in the closed state. Upon binding to PI(4)P on the LCV via the P4C domain, the ubiquitin ligase active site becomes accessible, leading to an increase in E3 ubiquitin ligase activity. In this model, the precise molecular mechanism for ubiquitin ligation remains to be explored. More importantly, the specific substrates that are ubiquitinated by SidC are still unknown. Future experiments are certainly needed to address how host ER vesicle trafficking is rerouted by the ubiquitin ligase activity of SidC.
